Precision Vaccinations News
Search
Inline CSS
Clinical Trials
Lab Tests
Subscribe
Trials
Labs
Subscribe
Home
Dengue
Flu
Measles
RSV
STD
Travel
Vaccines
Bladder Cancer
Fact check in progress
Apr 23
3 min read
US FDA Approves IL-15 Superagonist for Treating Bladder Cancer
ImmunityBio Anktiva N-803 Plus BCG vaccination is an FDA approved bladder cancer therapy
Bladder Cancer
Fact checked by
Robert Carlson, MD
Feb 5
4 min read
Bladder Cancer Vaccine Therapy Offers Favorable Risk-Benefit Ratio
N-803 plus BCG bladder cancer vaccine therapy candidate has Prescription Drug User Fee Act date of April 23, 2024
Bladder Cancer
Fact checked by
Holly Lutmer PharmD
Oct 23
5 min read
Non-Muscle-Invasive Bladder Cancer Vaccine Candidate Competes Resubmission to US FDA
Anktiva N-803 is a first-in-class IL-15 superagonist plus BCG vaccine
Bladder Cancer
Fact checked by
Robert Carlson, MD
Jan 9
4 min read
Bladder Cancer Treatment Innovates in the Right Direction
N-803 Plus BCG in Patients with Bladder Cancer found effective
Bladder Cancer